Pharma stocks up on US tariff exemptions but analyst flags a $46B import cost risk

[
Pharma stocks up on US tariff exemptions but analyst flags a $46B import cost risk
[og_img]
https://www.investing.com/news/stock-market-news/pharma-stocks-up-on-us-tariff-exemptions-but-analyst-flags-a-46b-import-cost-risk-3964936


Investing.com